Literature DB >> 26443026

Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells.

Milena R Kaluđerović1, Marija Mojić, Santiago Gómez-Ruiz, Sanja Mijatović, Danijela Maksimović-Ivanić.   

Abstract

In vitro antitumor activity of various organogallium(III) complexes (1-8) has been tested against CT26CL25, HCT116, SW480 colon cancer cell lines. CV and MTT assays were used to assess on the antiproliferative effect of investigated organogallium(III) complexes. From the investigated complexes, the most active was found to be tetranuclear compound 8 against CT26CL25 cells. Flow cytometric analysis of the CT26CL25 cells upon the treatment with 8 was performed in order to determine the role of apoptosis, caspase activation, autophagy and proliferation rate on the cell death caused with this compound. Results indicate cytotoxic potential of the tetranuclear complex 8 by inducing caspase independent apoptosis and blocking most of the cells before first division.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26443026     DOI: 10.2174/1871520615666151007160319

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

1.  Biological study of the effect of water soluble [N-(2-hydroxybenzyl)-L-aspartato] gallium complexes on breast carcinoma and fibrosarcoma cells.

Authors:  Ahmed Mohsen; Charles Saby; Philippe Collery; Gilane Mohamed Sabry; Rasha Elsherif Hassan; Abdelfattah Badawi; Pierre Jeannesson; Didier Desmaële; Hamid Morjani
Journal:  J Biol Inorg Chem       Date:  2016-08-02       Impact factor: 3.358

2.  Arene Ruthenium(II) Complexes Bearing the κ-P or κ-P,κ-S Ph2P(CH2)3SPh Ligand.

Authors:  Sören Arlt; Vladana Petković; Gerd Ludwig; Thomas Eichhorn; Heinrich Lang; Tobias Rüffer; Sanja Mijatović; Danijela Maksimović-Ivanić; Goran N Kaluđerović
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.